HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Congressional Appropriators Urge FDA Action On Cosmetic Lead Limits

This article was originally published in The Rose Sheet

Executive Summary

House and Senate committee reports on proposed FDA appropriations for fiscal 2015 direct the agency to respond to a nearly three-year-old petition requesting an agency-sanctioned limit on trace lead in lipstick and other cosmetics. Appropriators set a March 15, 2015 deadline for FDA’s response.

You may also be interested in...



Congress Proposes Public-Private Partnership For CIR

In reports accompanying draft fiscal 2016 funding bills, both House and Senate committees recommend that FDA work with industry to explore formalizing the Cosmetic Ingredient Review via a public-private partnership similar to that in place with the U.S. Pharmacopeial Convention.

FDA Will Respond To Lipstick Lead-Limit Petition In March

According to President Obama’s fiscal 2016 budget request, FDA expects to meet the March 2015 due date imposed by Congress for responding to a citizen petition to set a maximum limit on lead in cosmetic products.

In Brief

Expected guidance on lead in cosmetics is still under development, CFSAN says; Avon finalizes settlement with SEC over China bribery charges. More news in brief.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019061

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel